Abstract The coronavirus disease 2019 (COVID-19) pandemic has stimulated tremendous
efforts to develop therapeutic strategies that target severe acute respiratory syndrome …

Members of the coronaviridae family are endemic to human populations and have caused
several epidemics and pandemics in recent history. In this review, we will discuss the …

The severe acute respiratory syndrome coronavirus 2 variant JN. 1 recently emerged as the
dominant variant despite having only one amino acid change on the spike (S) protein …

The COVID‐19 pandemic has caused an unprecedented health crisis and economic burden
worldwide. Its etiological agent SARS‐CoV‐2, a new virus in the coronavirus family, has …

A growing body of evidence shows that fragment crystallizable (Fc)-dependent antibody
effector functions play an important role in protection from severe acute respiratory …

Abstract SARS-CoV-2 vaccines, administered to billions of people worldwide, mitigate the
effects of the COVID-19 pandemic, however little is known about the molecular basis of …

The global coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has spawned an ongoing demand for …

Understanding the evolution of the B cell response to severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) variants is fundamental to design the next generation of …

Severe acute respiratory syndrome 2 Omicron BA. 4 and BA. 5 are characterized by high
transmissibility and ability to escape natural and vaccine induced immunity. Here we test the …

CTL-mediated killing of virally infected or malignant cells is orchestrated at the immune
synapse (IS). We hypothesized that SARS-CoV-2 may target lytic IS assembly to escape …